While pregnant, women need to be especially careful about what foods and medications that they put into their bodies. Early in the first trimester, while many women are not even aware that they are pregnant, the baby is at a heightened risk for birth defects due to medications being ingested by their mother. Our birth defects attorneys have been writing for months about the drug Topamax and its connection to cleft lip and palate birth defects.
Mothers Taking Active Ingredient in Topamax Three Times More Likely to have Children with Birth Defects
A recent study called Comparative Safety of Topiramate During Pregnancy, performed by researchers from Harvard University, MassGeneral Hospital for Children, and Loyola University in Chicago, has come to the conclusion that topiramate increases chances of birth defects. According to the study, women who take the active ingredient in the medication Topamax during their first trimester of pregnancy increase the risk of their children being born with major oral birth defects. The study analyzed statistics of 6,456 pregnant women and “compared the frequency of adverse pregnancy outcomes for those who had used topiramate during their first trimester to a control group.” The results were that the children whose mothers took topiramate were almost three times more likely to be born with a birth defect, 3.8 %, than the mothers who did not, 1.3 %.
Birth Defects Lawyers in New Jersey and Philadelphia
If you are a pregnant and currently taking Topamax or any drug containing topiramate, speak with your doctor as soon as possible about other, safer options. If you are a parent who has recently given birth to a child who suffers from a birth defect that you believe can be attributed to a prescription drug, contact the Mininno Law Office to speak with birth defects lawyers and discuss your legal rights. You may also call for a free case evaluation and consultation at (856) 833-0600 in New Jersey, or (215) 567-2380 in Philadelphia.
Many parents are alarmed after their child’s surgery when new scars are red. During the healing process, the body re-routes blood vessles to the scar to bring an extra supply of blood, creating that red color. The red will progressively darken for about three months and will be raised off the skin and stiff to the touch. Eventually, the scar will fade, soften, and flatten. Ultimately, the scar should look like a soft, flat, white line.
As data from studies shows the possible correlation between Topamax and cleft lip, the FDA states that there will be a stronger label on the product. The pregnancy category of the drug has been changed. The warning will now show Topamax in category D, as opposed to its former spot in category C. There has been positive evidence of fetal risk in human beings, which is the reason for the change of category.